Effectiveness and Safety of Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This research is a clinical study with a single-blind randomized clinical trial design
(randomized controlled trial) in multicenters at two Dermatology and Venereology Education
centers in Indonesia.
This study aims to determine the effectiveness and safety of PSP as adjuvant therapy for
melasma.
This research will be attended by 33 research subjects